interleukin 12 การใช้

• More information is at the Talk : Interleukin 12 page.
• See Talk : Interleukin 12 for a little more discussion on the issue.
• A protein called Interleukin 12 is responsible for the differentiation of naive T cells into inflammatory T cells.
• Its cancer drug, Interleukin 12, is in the final clinical trials for approval under the new process.
• The immature cells fail to activate T-cells and produce less interleukin 12 than wild-type dendritic cells.
• Interleukin 12 ( IL-12 ) is produced by activated antigen-presenting cells ( dendritic cells, macrophages ).
• This gene encodes a subunit of the cytokine Interleukin 12 ( IL-12 ) that acts on Th1 and Th2 cells.
• Interleukin 12 ( IL-12 ) is a disulphide-bonded heterodimer consisting of a 35kDa alpha subunit and a 40kDa beta subunit.
• It is directed against interleukin 12 and interleukin 23, naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders.
• This gene encodes a subunit of interleukin 12, a cytokine that acts on T and natural killer cells, and has a broad array of biological activities.
• Roche has two compounds in early clinical trials, Interleukin 12 and capecitabine, that could get to market more quickly if the FDA quickens its approval pace further, Drews said.
• Its cancer drug, Interleukin 12, now is in the final clinical trials for approval under the new process, although years of additional research would be needed under the old approach.
• The protein encoded by this gene is a secreted glycoprotein, which is a member of the hematopoietin receptor family related to the p40 subunit of interleukin 12 ( IL-12 ).
• This results in an increased production of TNF-?, interleukin 1, interleukin 6, interleukin 8, interleukin 12, and other cytokines, as well as ICAM-1.
• Interleukin 12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor like subunit encoded by this gene, and a 35 kD subunit encoded by IL12A . This cytokine is expressed by activated macrophages that serve as an essential inducer of Th1 cells development.
• The article IL-12 and IL-12 Receptor ?1 Mutations seems somewhat redundant to the main article Interleukin 12 and I think that information at IL-12 and IL-12 Receptor ?1 Mutations would be better served as a section of the main Interleukin 12.
• The article IL-12 and IL-12 Receptor ?1 Mutations seems somewhat redundant to the main article Interleukin 12 and I think that information at IL-12 and IL-12 Receptor ?1 Mutations would be better served as a section of the main Interleukin 12.
• Human and animal studies have provided evidence of decreased Th1 and Th17 immune responses with a shift to Th2 cytokine production resulting in significantly decreased levels of interleukin 12 and IFNy with simultaneous increases in the regulatory T cells, interleukin 4, interleukin 5 and interleukin 10 of test subjects.
• There is a stubby orphaned article at IL-12 and IL-12 Receptor ?1 Mutations which would probably do better as a subsection of the main article, which I " think " is Interleukin 12 but I don't know enough about the topic to actually make the merge properly.